TNNT1
Basic information
Region (hg38): 19:55132698-55149206
Links
Phenotypes
GenCC
Source:
- nemaline myopathy 5 (Supportive), mode of inheritance: AR
- nemaline myopathy 5 (Strong), mode of inheritance: AR
- nemaline myopathy 5 (Strong), mode of inheritance: AR
- nemaline myopathy 5C, autosomal dominant (Limited), mode of inheritance: AD
- nemaline myopathy 5C, autosomal dominant (Limited), mode of inheritance: AD
- nemaline myopathy 5 (Definitive), mode of inheritance: AR
- nemaline myopathy (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Nemaline myopathy 5C, autosomal dominant; Nemaline myopathy 5A, severe infantile; Nemaline myopathy 5B, childhood-onset | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 10952871; 29178646; 29931346; 31970803; 35165004; 35510366; 35833674 |
ClinVar
This is a list of variants' phenotypes submitted to
- Nemaline_myopathy_5 (283 variants)
- not_provided (79 variants)
- Inborn_genetic_diseases (31 variants)
- not_specified (15 variants)
- Nemaline_myopathy_5B,_autosomal_recessive,_childhood-onset (6 variants)
- TNNT1-related_disorder (6 variants)
- Nemaline_myopathy_5C,_autosomal_dominant (4 variants)
- Nemaline_Myopathy,_Recessive (2 variants)
- Myopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNNT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003283.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 54 | 57 | ||||
| missense | 114 | 122 | ||||
| nonsense | 10 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 13 | |||||
| splice donor/acceptor (+/-2bp) | 10 | 14 | ||||
| Total | 22 | 18 | 117 | 57 | 3 |
Highest pathogenic variant AF is 0.00015174306
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TNNT1 | protein_coding | protein_coding | ENST00000588981 | 13 | 16561 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 7.02e-14 | 0.0172 | 125711 | 0 | 37 | 125748 | 0.000147 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.990 | 139 | 176 | 0.790 | 0.0000121 | 1800 |
| Missense in Polyphen | 54 | 90.956 | 0.5937 | 824 | ||
| Synonymous | -0.324 | 66 | 62.7 | 1.05 | 0.00000385 | 486 |
| Loss of Function | -0.0806 | 20 | 19.6 | 1.02 | 8.48e-7 | 262 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000120 | 0.000119 |
| Ashkenazi Jewish | 0.0000993 | 0.0000992 |
| East Asian | 0.0000545 | 0.0000544 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000179 | 0.000167 |
| Middle Eastern | 0.0000545 | 0.0000544 |
| South Asian | 0.000362 | 0.000359 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity.;
- Disease
- DISEASE: Nemaline myopathy 5 (NEM5) [MIM:605355]: A form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination. Nemaline myopathy type 5 is a severe and progressive form common among Old Order Amish. Affected infants display tremors with hypotonia and mild contractures of the shoulders and hips. Proximal contractures progressively weaken and a pectus carinatum deformity develops before children die of respiratory insufficiency, usually in the second year. {ECO:0000269|PubMed:10952871}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Disopyramide Action Pathway;Procainamide (Antiarrhythmic) Action Pathway;Phenytoin (Antiarrhythmic) Action Pathway;Fosphenytoin (Antiarrhythmic) Action Pathway;Bopindolol Action Pathway;Timolol Action Pathway;Carteolol Action Pathway;Bevantolol Action Pathway;Practolol Action Pathway;Dobutamine Action Pathway;Isoprenaline Action Pathway;Arbutamine Action Pathway;Amiodarone Action Pathway;Levobunolol Action Pathway;Metipranolol Action Pathway;Mexiletine Action Pathway;Lidocaine (Antiarrhythmic) Action Pathway;Quinidine Action Pathway;Sotalol Action Pathway;Epinephrine Action Pathway;Betaxolol Action Pathway;Atenolol Action Pathway;Alprenolol Action Pathway;Acebutolol Action Pathway;Muscle/Heart Contraction;Diltiazem Action Pathway;Propranolol Action Pathway;Pindolol Action Pathway;Penbutolol Action Pathway;Oxprenolol Action Pathway;Metoprolol Action Pathway;Esmolol Action Pathway;Bisoprolol Action Pathway;Bupranolol Action Pathway;Nebivolol Action Pathway;Amlodipine Action Pathway;Verapamil Action Pathway;Nitrendipine Action Pathway;Nisoldipine Action Pathway;Nimodipine Action Pathway;Ibutilide Action Pathway;Tocainide Action Pathway;Flecainide Action Pathway;Isradipine Action Pathway;Nifedipine Action Pathway;Felodipine Action Pathway;Nadolol Action Pathway;Carvedilol Action Pathway;Labetalol Action Pathway;Striated Muscle Contraction;Striated Muscle Contraction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.209
Intolerance Scores
- loftool
- 0.132
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.49
Haploinsufficiency Scores
- pHI
- 0.681
- hipred
- N
- hipred_score
- 0.337
- ghis
- 0.540
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.503
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnnt1
- Phenotype
- muscle phenotype;
Gene ontology
- Biological process
- skeletal muscle contraction;muscle contraction;transition between fast and slow fiber;muscle filament sliding;slow-twitch skeletal muscle fiber contraction;sarcomere organization;negative regulation of muscle contraction;cardiac muscle contraction
- Cellular component
- cytosol;troponin complex
- Molecular function
- calcium ion binding;protein binding;tropomyosin binding;calcium-dependent ATPase activity;troponin T binding